Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
Niger M, Nichetti F, Fornaro L, Pircher C, Morano F, Palermo F, Rimassa L, Pressiani T, Berardi R, Gardini AC, Sperti E, Salvatore L, Melisi D, Bergamo F, Siena S, Mosconi S, Longarini R, Arcangeli G, Corallo S, Delliponti L, Tamberi S, Fea E, Brandi G, Rapposelli IG, Salati M, Baili P, Miceli R, Ljevar S, Cavallo I, Sottotetti E, Martinetti A, Busset MDD, Sposito C, Di Bartolomeo M, Pietrantonio F, de Braud F, Mazzaferro V. Niger M, et al. Among authors: cavallo i. BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0. BMC Cancer. 2024. PMID: 38711003 Free PMC article. No abstract available.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
Niger M, Nichetti F, Fornaro L, Pircher C, Morano F, Palermo F, Rimassa L, Pressiani T, Berardi R, Gardini AC, Sperti E, Salvatore L, Melisi D, Bergamo F, Siena S, Mosconi S, Longarini R, Arcangeli G, Corallo S, Delliponti L, Tamberi S, Fea E, Brandi G, Rapposelli IG, Salati M, Baili P, Miceli R, Ljevar S, Cavallo I, Sottotetti E, Martinetti A, Busset MDD, Sposito C, Di Bartolomeo M, Pietrantonio F, de Braud F, Mazzaferro V. Niger M, et al. Among authors: cavallo i. BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6. BMC Cancer. 2024. PMID: 38589856 Free PMC article. Clinical Trial.
A breast cancer clinical registry in an Italian comprehensive cancer center: an instrument for descriptive, clinical, and experimental research.
Baili P, Torresani M, Agresti R, Rosito G, Daidone MG, Veneroni S, Cavallo I, Funaro F, Giunco M, Turco A, Amash H, Scavo A, Minicozzi P, Bella F, Meneghini E, Sant M. Baili P, et al. Among authors: cavallo i. Tumori. 2015 Jul-Aug;101(4):440-6. doi: 10.5301/tj.5000341. Epub 2015 May 2. Tumori. 2015. PMID: 25953447
[Turn-over of non-tenured public health research personnel in an Italian public research institute (IRCCS).].
Meneghini E, Lillini R, Ballarini R, Florita A, Cavallo I, Funaro F, Bonfarnuzzo S, Cifalà A, Margutti C, Perrotta I, Bonacci P, Carletti F, Fracchiolla V, Morelli M, Aiello A, Pizzo F, Gabaldi P, Apolone G, Baili P. Meneghini E, et al. Among authors: cavallo i. Recenti Prog Med. 2019 Feb;110(2):75-85. doi: 10.1701/3112.31002. Recenti Prog Med. 2019. PMID: 30843532 Italian.
Microbial biofilm correlates with an increased antibiotic tolerance and poor therapeutic outcome in infective endocarditis.
Di Domenico EG, Rimoldi SG, Cavallo I, D'Agosto G, Trento E, Cagnoni G, Palazzin A, Pagani C, Romeri F, De Vecchi E, Schiavini M, Secchi D, Antona C, Rizzardini G, Dichirico RB, Toma L, Kovacs D, Cardinali G, Gallo MT, Gismondo MR, Ensoli F. Di Domenico EG, et al. Among authors: cavallo i. BMC Microbiol. 2019 Oct 21;19(1):228. doi: 10.1186/s12866-019-1596-2. BMC Microbiol. 2019. PMID: 31638894 Free PMC article.
The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
Di Domenico EG, Marchesi F, Cavallo I, Toma L, Sivori F, Papa E, Spadea A, Cafarella G, Terrenato I, Prignano G, Pimpinelli F, Mastrofrancesco A, D'Agosto G, Trento E, Morrone A, Mengarelli A, Ensoli F. Di Domenico EG, et al. Among authors: cavallo i. Microbiol Spectr. 2021 Sep 3;9(1):e0055021. doi: 10.1128/Spectrum.00550-21. Epub 2021 Aug 18. Microbiol Spectr. 2021. PMID: 34406812 Free PMC article.
Efficacy of sodium hypochlorite in overcoming antimicrobial resistance and eradicating biofilms in clinical pathogens from pressure ulcers.
Fabrizio G, Sivori F, Cavallo I, Truglio M, Toma L, Sperati F, Francalancia M, Obregon F, Pamparau L, Kovacs D, Pimpinelli F, Di Domenico EG. Fabrizio G, et al. Among authors: cavallo i. Front Microbiol. 2024 Jul 10;15:1432883. doi: 10.3389/fmicb.2024.1432883. eCollection 2024. Front Microbiol. 2024. PMID: 39050624 Free PMC article.
Ceftolozane-Tazobactam for Febrile Neutropenia Treatment in Hematologic Malignancy Patients Colonized by Multi-Resistant Enterobacteriaceae: Preliminary Results from a Prospective Cohort Study.
Marchesi F, Toma L, Di Domenico EG, Cavallo I, Spadea A, Prignano G, Pimpinelli F, Papa E, Terrenato I, Ensoli F, Mengarelli A. Marchesi F, et al. Among authors: cavallo i. Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020065. doi: 10.4084/MJHID.2020.065. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 32952976 Free PMC article. No abstract available.
51 results